SCHEMBL2322967

SCHEMBL2322967

Brc1ccc(OCCN2CCCC2)c(Br)c1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 1/20 0.67
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
SMN1; SMN2 Q16637 3/20 0.59
LMNA P02545 1/20 0.59
LTA4H P09960 1/20 0.56
PTGS2 P35354 1/20 0.56
HRH3 Q9Y5N1 2/20 0.54
KDM4E B2RXH2 5/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
ALDH1A1 P00352 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ESR1 P03372 2/20 0.51
ESR2 Q92731 2/20 0.51
TDP1 Q9NUW8 2/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4517578 0.86 HTR1B (0.53) HTR1BMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL15441046 0.84 SMN1; SMN2 (0.57) HTR1BMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2322184 0.84 LTA4H (0.61) HTR1BMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL6593991 0.84 MEN1 (0.85) HTR1BMEN1KMT2ASMN1; SMN2LTA4H
SCHEMBL2321215 0.84 SMN1; SMN2 (0.57) HTR1BMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2329109 0.84 ALDH1A1 (0.67) MEN1KMT2ASMN1; SMN2LMNALTA4H
SCHEMBL227430 0.83 LTA4H (0.60) HTR1BMEN1KMT2ASMN1; SMN2LTA4H
SCHEMBL226018 0.83 LTA4H (0.60) HTR1BMEN1KMT2ASMN1; SMN2LTA4H
SCHEMBL2323789 0.83 LTA4H (0.66) HTR1BMEN1KMT2ASMN1; SMN2LTA4H
SCHEMBL4478052 0.82 MEN1 (0.61) HTR1BMEN1KMT2ASMN1; SMN2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558578-B1 NOVEL ALKYNE COMPOUNDS HAVING AN MCH ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM PHARMA (DE) 2013-03-13 EP disclosed
EP-2357173-A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-08-17 EP disclosed
EP-1558578-A1 NOVEL ALKYNE COMPOUNDS HAVING AN MCH ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-08-03 EP disclosed
WO-2004039780-A1 NOVEL ALKYNE COMPOUNDS HAVING AN MCH ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-05-13 WO disclosed